Lofibra 134 mg Gate 323 (Lofibra 134 mg)
Generic Name: fenofibrate
Pill with imprint Lofibra 134 mg Gate 323 is Blue, Capsule-shape and has been identified as Lofibra 134 mg. It is supplied by Gate Pharmaceuticals.
Lofibra is used in the treatment of hypertriglyceridemia; hyperlipoproteinemia type iia, elevated ldl; hyperlipoproteinemia type iib, elevated ldl vldl; hyperlipoproteinemia type v, elevated chylomicrons vldl; hyperlipoproteinemia (and more), and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Lofibra 134 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Lofibra 134 mg Gate 323
Lofibra
- Generic Name:
- fenofibrate
- Imprint:
- Lofibra 134 mg Gate 323
- Strength:
- 134 mg
- Color:
- Blue
- Size:
- 18.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Fibric acid derivatives
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Gate Pharmaceuticals
- Inactive Ingredients:
- croscarmellose sodium
crospovidone
lactose monohydrate
magnesium stearate
povidone k25
corn starch
sodium lauryl sulfate
D&C Red No. 28
FD&C Blue No. 1
titanium dioxide
gelatin
Note: Inactive ingredients may vary.
More about Lofibra (fenofibrate)
- Lofibra Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- En Español
- Drug class: fibric acid derivatives
Consumer resources
Other brands: TriCor, Antara, Triglide, Lipofen, Fenoglide
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
